Interestingly, four EMT genes (MAP1B, SNAI2, MMP2, and WNT5A) were also involved in neurological diseases, brain metastasis, and response to platinum-based chemotherapy or tyrosine–kinase inhibitors. Here, MMP2 is linked to nervous system disorder.